A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis through 52 weeks, according to phase 3 trial results published in Annals of ...
Since entering the allergy field, Priya J. Bansal, MD, FAAAAI, FACAAI, has seen positive changes, including the entry of more ...
A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...
Techno-Science on MSN16h
A new therapeutic target against asthma 🫁Despite advances in the treatment of patients with the most severe forms of asthma, progress remains to be made as half of ...
A mom in Minnesota is heading to prison for causing the death of her daughter after she refused to let the parents of one of ...
Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback